6578 Federal Register / Vol. 72, No. 28 / Monday, February 12, 2007 / Notices 

STATS ChipPAC Ltd., Singapore, 

Singapore; Supresta, Ardsley, NY; and 

UGS Corporation, Milford, OH have 

been added as parties to this venture. 

Also, Heraeus, Inc., West 

Conshohocken, PA; Total Parts Plus, 

Fort Walton Beach, FL; and Nortel, 

Toronto, Ontario, CANADA have 

withdrawn as parties to this venture. In 

addition, Alcatel and Lucent 

Technologies have merged with the 

name of the combined companies 

changed to Alcatel-Lucent, Paris, 

France. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and iNEMI 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On June 6, 1996, iNEMI filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 28, 1996 (61 FR 33774). 

The last notification was filed with 

the Department on January 5, 2006. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on February 8, 2006 (71 FR 6522). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 07–604 Filed 2–9–07; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Spray Drift Task Force 

Notice is hereby given that, on 

December 29, 2006, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), Spray 

Drift Task Force (‘‘SDTF’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of the antitrust 

plaintiffs to actual damages under 

specified circumstances. Specifically, 

AgValue Enterprises, Inc., Visalia, CA 

joined SDTF and was subsequently 

acquired by United Phosphorous, Inc., 

Trenton, NJ. Also, the membership 

formerly owned by AgValue Enterprises, 

Inc., Visalia, CA, but acquired by United 

Phosphorous, Inc., Trenton, NJ, was 

transferred to Etigra, LLC, Cary, NC. The 

membership formerly held by Griffin 

Corporation, Valdosta, GA, but acquired 

by E.I. duPont de Nemours and 

Company, Newark, DE, was transferred 

to Mitsui Chemicals, Tokyo, Japan. The 

membership formerly held by Alsan 

Research, Ankeny, IA, but acquired by 

Dow AgroSciences LLC, Indianapolis, 

IN, was transferred to Isagro, 

Morrisville, NC. The membership 

formerly held by Nations Ag II, LLC, 

Knoxville, TN, but acquired by 

Makhteshim-Agan of North America, 

Inc., Raleigh, NC, was transferred to 

Zhejiang Tide Crop Science Co., Ltd., 

Hangzhou, People’s Republic of China. 

Futhermore, UCB Chemicals 

Corporation, Gent, Belgium transferred 

its membership to Taminco, Inc., Gent, 

Belgium. Also, Arvesta Corporation, San 

Francisco, CA changed its name to 

Arysta LifeScience North America 

Corporation, and relocated to Cary, NC; 

Crompton Corporation, Bethany, CT 

changed its name to Chemtura 

Corporation; and Chimac-Agriphar SA, 

Ougree, Belgium changed its name to 

Agriphar SA. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and SDTF intends 

to file additional written notifications 

disclosing all changes in membership. 

On May 15, 1990, SDTF filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on July 5, 1990 (55 FR 27701). 

The last notification was filed with 

the Department on August 25, 2003. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on September 26, 2003 (68 FR 

55657). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 07–606 Filed 2–9–07; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on November 22, 

2006, Cambrex Charles City, Inc., 1205 

11th Street, Charles City, Iowa 50616, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) as a bulk manufacturer of the 

basic classes of controlled substances 

listed in schedule II: 

Drug Schedule 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Phenylacetone (8501) .................. II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for sales to its customers. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substances 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections being sent via regular mail 

should be addressed, in quintuplicate, 

to the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative/ODL; or 

any being sent via express mail should 

be sent to DEA Headquarters, Attention: 

DEA Federal Register Representative/ 

ODL, 2401 Jefferson-Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than April 13, 2007. 

Dated: February 5, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–2317 Filed 2–9–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2)(B) authorizing the importation 

of such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on October 

31, 2006, Fisher Clinical Services Inc., 

7554 Schantz Road, Allentown, 

Pennsylvania 18106, made application 

by letter to the Drug Enforcement 


sroberts on PROD1PC70 with NOTICES